Predict your next investment

Venture Capital
dolbyventures.com

See what CB Insights has to offer

Investments

80

Portfolio Exits

18

Funds

1

Partners & Customers

1

About Dolby Family Ventures

Dolby Family Ventures is an early stage venture firm focused on building great technology companies. The firm partners with best-in-class innovators and strong investment syndicate partners at the seed stage of a company's development. The fund honors the legacy of Ray Dolby and his commitment to engineers and their vision to solve the world's toughest problems. Dolby Family Ventures formalizes the Dolby family's ongoing multi-generational commitment to supporting talented entrepreneurs.

Dolby Family Ventures Headquarter Location

999 Brannan Street Suite 114

San Francisco, California, 94103,

United States

415-449-1005

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Dolby Family Ventures News

DigiLens Completes Second Close of Its Series D

Apr 7, 2022

Corning joins a diverse and impressive list of investors in this round that includes Samsung Electronics, Optimas Capital Management (a strategic investment arm of Goertek), Diamond Edge Ventures (the strategic investment arm of Mitsubishi Chemical Holdings Corporation), Alsop Louie Partners, 37 Interactive Entertainment, UDC Ventures (the corporate venture arm of Universal Display Corporation), and Dolby Family Ventures. After a funding round that included more than $50 million in new investments, DigiLens is now valued at over $530 million. The round solidifies DigiLens' waveguides as a de facto standard for smartglasses and allows the company to strengthen its licensing business model and extend its global offerings. DigiLens is a leader in holographic waveguides used for XR displays. The company has developed a patented optical platform and photopolymer technology that delivers best-in-class solutions using a unique, low-cost contact-copy manufacturing process. DigiLens enables OEM partners to design and build XR-enabled devices for the global automobile, enterprise, consumer, avionics, and military industries. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Dolby Family Ventures Investments

80 Investments

Dolby Family Ventures has made 80 investments. Their latest investment was in Ubotica as part of their Seed VC on May 5, 2022.

CBI Logo

Dolby Family Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/18/2022

Seed VC

Ubotica

$4.2M

Yes

3

3/10/2022

Series A

Diamond Age

$50M

No

15

2/4/2022

Unattributed VC - II

MindImmune Therapeutics

$5.35M

Yes

1

1/4/2022

Series C

Subscribe to see more

$99M

Subscribe to see more

10

12/7/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/18/2022

3/10/2022

2/4/2022

1/4/2022

12/7/2021

Round

Seed VC

Series A

Unattributed VC - II

Series C

Series C

Company

Ubotica

Diamond Age

MindImmune Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$4.2M

$50M

$5.35M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

15

1

10

10

Dolby Family Ventures Portfolio Exits

18 Portfolio Exits

Dolby Family Ventures has 18 portfolio exits. Their latest portfolio exit was Keyssa on December 10, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/10/2021

Acquired

2

10/14/2021

Acq - Pending

$99M

2

10/8/2021

IPO

4

8/10/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/26/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/10/2021

10/14/2021

10/8/2021

8/10/2021

6/26/2021

Exit

Acquired

Acq - Pending

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

2

4

10

10

Dolby Family Ventures Fund History

1 Fund History

Dolby Family Ventures has 1 fund, including Dolby Family Ventures.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/16/2014

Dolby Family Ventures

1

Closing Date

6/16/2014

Fund

Dolby Family Ventures

Fund Type

Status

Amount

Sources

1

Dolby Family Ventures Partners & Customers

1 Partners and customers

Dolby Family Ventures has 1 strategic partners and customers. Dolby Family Ventures recently partnered with Gladstone Institutes, and Evotec on July 7, 2015.

Date

Type

Business Partner

Country

News Snippet

Sources

7/23/2015

Partner

United States, and Germany

Article | By Dana G. Smith, PhD | July 23, 2015. The Gladstone Institutes Launches Novel Partnership with Dolby Family Ventures and Evotec AG

David Dolby , Managing Director , Dolby Family Ventures , joined forces with Gladstone Institute of Neurological Disease because its research has great potential to change the progression of Alzheimer 's disease .

1

Date

7/23/2015

Type

Partner

Business Partner

Country

United States, and Germany

News Snippet

Article | By Dana G. Smith, PhD | July 23, 2015. The Gladstone Institutes Launches Novel Partnership with Dolby Family Ventures and Evotec AG

David Dolby , Managing Director , Dolby Family Ventures , joined forces with Gladstone Institute of Neurological Disease because its research has great potential to change the progression of Alzheimer 's disease .

Sources

1

Dolby Family Ventures Team

3 Team Members

Dolby Family Ventures has 3 team members, including current Senior Managing Director, Pascal N. Levensohn.

Name

Work History

Title

Status

Pascal N. Levensohn

Senior Managing Director

Current

Andrew L. Krowne

NatWest, Barclays Capital, and Merrill

Managing Director

Current

Tracy Saxton

Frazier Healthcare Partners, Pivotal bioVenture Partners, Roche Venture Fund, SV Health Investors, UCSF Foundation, Geron, Threshold Pharmaceuticals, and Amgen

Managing Director

Current

Name

Pascal N. Levensohn

Andrew L. Krowne

Tracy Saxton

Work History

NatWest, Barclays Capital, and Merrill

Frazier Healthcare Partners, Pivotal bioVenture Partners, Roche Venture Fund, SV Health Investors, UCSF Foundation, Geron, Threshold Pharmaceuticals, and Amgen

Title

Senior Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.